Pharma Journalist -

ALX Oncology Holdings Inc. a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, and Tallac Therapeutics, Inc. (“Tallac”), a privately…
Read More...

Vir Biotechnology, Inc. and GlaxoSmithKline plc provided an update on the VIR-7831 (GSK4182136) arm of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic…
Read More...

The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA (lorlatinib), expanding the indication to include…
Read More...

Tempest Therapeutics, Inc., a clinical-stage oncology company developing first-in-class therapeutics that combine both precision and immune-mediated mechanisms, announced a clinical…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc. a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological…
Read More...

Vaxalto Biotherapeutics, Inc. (www.vaxalto.com), a pre-clinical stage biotechnology company focused on developing and commercializing novel engineered immunotherapeutic oncolytic…
Read More...

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, announced final efficacy data…
Read More...

WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, announced that it has…
Read More...

ObvioHealth, a global virtual research organization or VRO, announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital…
Read More...

Merck, known as MSD outside the United States and Canada, announced it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of…
Read More...